Home・Akciju saraksts・Codexis Inc

Codexis Inc

Slēgts

SektorsVeselības aprūpe

1.39 -6.08

Pirkt Pārdot

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

1.37

Max

1.3900000000000001

Galvenie mērījumi
By Trading Economics
Ienākumi	-18M -8.7M
Pārdošana	-24M 15M
EPS	-0.1
Peļņas marža	-57.083
Darbinieki	146
EBITDA	-23M -6.4M

Rekomendācijas
By TipRanks
Rekomendācijas	Pirkt (spēcīgs)
Prognoze 12 mēnešiem	+423.57% upside

Dividendes
By Acuity
Nākamie ieņēmumi	2026. g. 11. aug.

Tirgus statistika
By TradingEconomics
Tirgus kapitalizācija	-87M 141M
Iepriekšējā atvēršanas cena	7.47
Iepriekšējā slēgšanas cena	1.39

Ziņu noskaņojums

By Acuity

91%

5 / 340 Rangs Healthcare

Codexis Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 31. jūl. 20:02 UTC

Codexis Inc shares are trading lower today, continuing a broader decline. The stock is near the lower end of its one-month range.

2026. g. 30. jūl. 20:09 UTC

Codexis Inc shares are higher today, continuing their rise since Wednesday's close. Broader market volatility is influenced by mixed economic signals.

2026. g. 29. jūl. 19:47 UTC

Macro Event

Codexis Inc shares are lower amid broader market declines and heightened volatility following the Federal Reserve's decision to keep interest rates steady.

2026. g. 28. jūl. 19:51 UTC

Codexis Inc. shares are trading lower today, reflecting a downward trend since Monday, with a notable decline from an earlier session high.

2026. g. 27. jūl. 19:21 UTC

News

Codexis Inc shares are higher today, supported by early customer orders and interest from CDMOs. The stock remains up since Friday's close.

2026. g. 24. jūl. 19:01 UTC

News

Codexis Inc shares are lower following a public offering of 16.67 million shares at $1.50 each, below Thursday's close of $1.99.

2026. g. 23. jūl. 23:51 UTC

News

Codexis Inc announced a public offering of common stock, contributing to a notable decline in shares during after-market trading.

2026. g. 22. jūl. 20:01 UTC

Codexis Inc shares are lower during Wednesday's session, continuing a trend of declines since Tuesday's close. The stock remains below its 20-day moving average.

Salīdzinājums

Cenas izmaiņa

Codexis Inc Prognoze

Cenas mērķis

By TipRanks

423.57% augšup

Prognoze 12 mēnešiem

Vidējais 7.33 USD 423.57%

Augstākais 11 USD

Zemākais 2 USD

Pamatojoties uz 4 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Codexis Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt (spēcīgs)

4 ratings

Pirkt

Turēt

Pārdot

Pamatojoties uz 4 analītiķiem, kas pēdējo 3 mēnešu laikā snieguši akciju vērtējumus instrumentam Codexis Inc — pēdējo 3 mēnešu laikā.

Noskaņojums

By Acuity

5 / 340 Rangs Veselības aprūpe

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

Par Codexis Inc

Codexis, Inc. discovers, develops, and sells enzymes and other proteins. The company offers CodeEvolver, a technology platform, which helps in developing and delivering biocatalysts that perform chemical transformations and enhance the efficiency and productivity of manufacturing processes. It offers biocatalyst products and services. The company also provides biocatalyst screening and protein engineering services. In addition, the company is currently developing its proprietary ECO Synthesis(tm) manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. It has a collaboration agreement with Nestlé Health Science to develop CDX-7108 for the treatment of exocrine pancreatic insufficiency. The company sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. The company was incorporated in 2002 and is headquartered in Redwood City, California.